The subject is human immunodeficiency virus (HIV) positive
Patients that are known to be positive for human immunodeficiency virus (HIV) are not eligible; note: inclusion of HIV positive patients will be considered at a later date
The patient must NOT have a known positive test for human immunodeficiency virus (HIV); patients do not need to be screened for HIV; patients with HIV are excluded
Human immunodeficiency virus (HIV) positive patients
Human Immunodeficiency Virus (HIV) positive
Positive human immunodeficiency virus (HIV) status.
Patients who are human immunodeficiency virus (HIV) positive on highly active anti-retroviral therapy (HAART) will be excluded from the study
Patients known to be human immunodeficiency (HIV)-positive receiving anti-retroviral therapy are excluded from the study
Patients who are serologically positive for human immunodeficiency virus (HIV)
Positive for human immunodeficiency virus (HIV)
Human immunodeficiency virus (HIV)-positive
Human immunodeficiency virus (HIV)-positive patients are NOT excluded from the study
Human immunodeficiency virus (HIV)-positive patients receiving anti-retroviral therapy are excluded from this study; HIV positive patients not receiving antiretroviral therapy are excluded
Patients who are human immunodeficiency virus positive (HIV+)
Subjects who have tested positive for human immunodeficiency virus (HIV)
Patients who are positive for human immunodeficiency virus (HIV)
DONOR: Human immunodeficiency virus (HIV) positive
Positive human immunodeficiency virus (HIV) antibody at Screening
Human immunodeficiency virus (HIV) positive subjects are excluded
Human immunodeficiency virus (HIV) positive patients
Human immunodeficiency virus (HIV)-positive patients are ineligible
Known human immunodeficiency virus (HIV)-positive participants (even if on combination retrovirals, participant will be excluded)
Human immunodeficiency virus (HIV)-positive patients receiving anti-retroviral therapy are excluded from this study
Positive human immunodeficiency virus (HIV) status
Human immunodeficiency virus (HIV)-positive patients receiving anti-retroviral therapy are excluded from this study; HIV positive patients not receiving antiretroviral therapy are excluded
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV) positive
Is human immunodeficiency virus (HIV) positive
Know to be human immunodeficiency virus (HIV) positive
Patients known to be human immunodeficiency virus (HIV) positive who are not receiving anti-retroviral therapy will be excluded
Has a known history of human immunodeficiency virus (HIV); HIV-positive patients receiving anti-retroviral therapy are excluded from this study; HIV positive patients not receiving antiretroviral therapy are excluded
Patients can be human immunodeficiency virus (HIV) positive or negative
Human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study
Human immunodeficiency virus (HIV) positive
Because patients with immune deficiency are not expected to respond to this therapy, human immunodeficiency virus (HIV)-positive patients are excluded from the study
Human immunodeficiency virus (HIV) positive patients are ineligible
HIV1 (human immunodeficiency virus-1) or HIV2 positive
DONOR: Human immunodeficiency virus (HIV) positive
HIV1 (human immunodeficiency virus-1) or HIV2 positive
Known human immunodeficiency virus (HIV)-positive patients are excluded from the study; for patients receiving combination anti-retroviral therapy; screening for HIV status will not be performed
Human immunodeficiency virus (HIV)-positive patients
Human immunodeficiency virus (HIV)-positive
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded
Human immunodeficiency virus (HIV)-positive patients are excluded
Positive human immunodeficiency virus antibody
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV)-positive patients are excluded from the study
Patient who is human immunodeficiency virus (HIV)-positive
Patient is human immunodeficiency virus (HIV)-positive
2nd BMT, human immunodeficiency virus (HIV)-1 positive
Human immunodeficiency virus (HIV)-positive
Positive human immunodeficiency virus (HIV) antibody at Screening
Human immunodeficiency virus (HIV) infected patients (defined as HIV-1/HIV-2 antibody positive).
Human immunodeficiency virus (HIV) positive
Known human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study
Human immunodeficiency virus (HIV)-positive patients
Positive for human immunodeficiency virus (HIV)
Patients who are positive for human immunodeficiency virus type 1 (HIV-1) and are receiving combination anti-retroviral therapy
Patients who are human immunodeficiency virus positive (HIV+) will be excluded
Human immunodeficiency virus (HIV) positive patients will be excluded
Human immunodeficiency virus (HIV)-positive patients
Human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study
Human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study; note: HIV testing is not required for entry into this protocol
Human immunodeficiency virus (HIV)-positive patients are excluded from this study
Human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study
Human immunodeficiency virus (HIV)-positive patients and those with other acquired/inherited immunodeficiency
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV)-positive subjects are excluded from the study
Patients who are positive for human immunodeficiency virus (HIV)
Human immunodeficiency virus (HIV)-positive
Patients known to be human immunodeficiency virus (HIV) positive and receiving highly active anti-retroviral therapy (HAART)
Human immunodeficiency virus (HIV) positive patients
Positive for Human Immunodeficiency Virus (HIV).
Subjects positive for Human Immunodeficiency Virus (HIV)
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV) negative or positive
Known human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study
EXCLUSION CRITERIA FOR TRANSPLANT PHASE: Human immunodeficiency virus (HIV)-positive
Human immunodeficiency virus (HIV) positive patients or hepatitis B or C positive patients
Human immunodeficiency virus (HIV)-positive
Human immunodeficiency virus (HIV)-positive patients
Human immunodeficiency virus (HIV) positive patients
Participant has tested positive for human immunodeficiency virus (HIV).
Human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study; note: HIV testing is not required for entry into this protocol
Human Immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV)-positive patients are excluded
Patients who are human immunodeficiency virus positive (HIV+)
Subject has tested positive for human immunodeficiency virus (HIV).
Human immunodeficiency virus (HIV)-positive patients are excluded
Human immunodeficiency virus (HIV) positive patients are not eligible for this protocol; hepatitis B and C positive patients will be evaluated on a case-by-case basis
Human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV) positive patients
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV) positive (highly immunosuppressive treatment)
Patients who are serologically true-positive for human immunodeficiency virus (HIV)
Patients who are human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV) positive
Positive human immunodeficiency virus (HIV) infection at screening
Human immunodeficiency virus (HIV)-positive patients
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV)-positive patients are ineligible
Positive for human immunodeficiency virus (HIV) infection
Human immunodeficiency virus (HIV) positive patients will be excluded
Human immunodeficiency virus-positive patients receiving combination anti-retroviral therapy are excluded from the study
Human immunodeficiency virus (HIV) positive patients who are not on retroviral therapy will not be excluded from cohort 1, the normal liver function cohort\r\n* HIV positive patients who are not on retroviral therapy will be excluded from cohorts 2-4
A history of human immunodeficiency virus (HIV) antibody positive or tests positive for HIV if tested at screening
Human immunodeficiency virus (HIV) positive
Human immunodeficiency virus (HIV)-positive patients receiving anti-retroviral therapy are excluded from this study
Human immunodeficiency virus (HIV)-positive patients are ineligible
Human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded
Human immunodeficiency virus (HIV) positive patients are not eligible
Human immunodeficiency virus (HIV) - positive participants receiving anti-retroviral therapy
Positive for presence of human immunodeficiency virus type 1 or 2 (HIV 1 and HIV 2).
Patients who are human immunodeficiency virus (HIV)-positive are excluded from the study
Human immunodeficiency virus (HIV)-positive patients receiving anti-retroviral therapy are excluded from this study; HIV positive patients not receiving antiretroviral therapy are excluded
Known human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study
Known human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study
Human immunodeficiency virus (HIV)-positive patients on antiretroviral therapy are excluded from the study
Human immunodeficiency virus (HIV)-positive status
HIV1 (human immunodeficiency virus-1) or HIV2 positive
Human immunodeficiency virus (HIV)-positive participants are ineligible
Patients who are known to be serologically positive for human immunodeficiency virus (HIV) and are receiving antiviral therapy
Be human immunodeficiency virus (HIV)-positive
Human immunodeficiency virus (HIV)-positive participants are excluded
Human immunodeficiency virus (HIV)-positive patients are ineligible
Human immunodeficiency virus (HIV)-positive patients receiving combination anti-retroviral therapy are excluded from the study